Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Interventional Cardiac Electrophysiology
Metadata
Title
Teaching Interventional Electrophysiology: Is Revision of Core Curricula in Order?
Author
Sanjeev Saksena
Publication date
01-06-1998
Publisher
Kluwer Academic Publishers
Published in
Journal of Interventional Cardiac Electrophysiology / Issue 2/1998
Print ISSN: 1383-875X
Electronic ISSN: 1572-8595
DOI
https://doi.org/10.1023/A:1009781513616

Other articles of this Issue 2/1998

Journal of Interventional Cardiac Electrophysiology 2/1998 Go to the issue

OriginalPaper

Coronary Blood Flow Changes During Atrioventricular Sequential Pacing with Different Atrioventricular Delays in Normal Individuals

OriginalPaper

Acute Evaluation of a Preformed Single-pass VDD/DDD Pacing Lead

OriginalPaper

The Ablate and Pace Trial: A Prospective Study of Catheter Ablation of the AV Conduction System and Permanent Pacemaker Implantation for Treatment of Atrial Fibrillation

OriginalPaper

Electrophysiologic Characteristics of a Dilated Atrium in Patients with Paroxysmal Atrial Fibrillation and Atrial Flutter

Legacy

40 Years of Implantable Cardiac

OriginalPaper

Design and Implementation of the Dual Site Atrial Pacing to Prevent Atrial Fibrillation (DAPPAF) Clinical Trial

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits